Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Mar 1, 2022
Sunny Jain is the Founder and CEO of Floré by Sun Genomics and is driven to better understand the microbe cells that live inside of our intestinal tract and all around our body. With a history of working at Illumina, Sunny is studying the DNA from those cells, the microbiome, to understand their function and how they contribute to our overall health.
Sunny explains, "Sun Genomics has created the world's only precision probiotic, And it utilizes AI, DNA sequencing, biome chromatics, and e-health technology. Our technology helps us build the largest database of microbiomes that are sequenced via metagenomics, or whole genome sequencing, to understand the modulatory effects or the changing effects that food ingredients and probiotics can have for 80 plus million Americans that suffer from gut health issues every year."
"So, you truly are unique, from a gut microbiome perspective. Our human DNA is 99.9 percent similar. So, we're very identical from a human DNA perspective. But the DNA from microbes of the gut, you're maybe 10 percent similar, and you are 90 percent unique from the gut microbiome."
"And this is really where I think precision medicine can enable a lot of advancement to our human health. It is really within that large, vast difference where we will be able to find much more customized solutions."
@SunGenomics #SunGenomics #GutHealth #Probiotics #Microflora #CustomizedProbiotics #Microbiome #SanDiego
